NEW YORK, May 1 (Reuters) - Purdue Pharma said on Friday that it has ceased operations and concluded its bankruptcy, re-emerging as a nonprofit focused on treating opioid addiction, overseen by a ...
A federal judge has sentenced OxyContin maker Purdue Pharma to pay the government $225 million, ending the government’s yearslong criminal case and allowing the pharmaceutical company accused of ...
Add Yahoo as a preferred source to see more of our stories on Google. Purdue Pharma, the maker of the prescription opioid OxyContin, is headquartered in this building at 201 Tresser Blvd., in downtown ...
Purdue Pharma, the bankrupted drug manufacturer at the center of the nation’s yearslong opioid epidemic, shut down May 1. The closure is part of a $7.4 billion deal reached after Purdue and the ...
Knoa Pharma's new CEO, Michael Goettler, will lead a company that was created through Purdue Pharma's bankruptcy process.
Mary Jannotta sliced meat and cheese behind deli counters at Acme and Pathmark supermarkets in the Philadelphia suburbs for decades, developing aches that came with working on her feet. A botched back ...
In Purdue, the Supreme Court held that the Bankruptcy Code does not authorize a Chapter 11 plan to release and enjoin claims against a nondebtor without the consent of affected claimants. Harrington v ...
On March 31, 2026, US District Court Chief Judge Colm F. Connolly of the District of Delaware affirmed a bankruptcy court order recognizing Crédito Real, S.A.B. de C.V., SOFOM, E.N.R.’s (“Crédito Real ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results